Clinical trial
TELI COM - Telithromycin in Children With Otitis Media
NCT00315003 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00315003 |
|---|---|
| Title | TELI COM - Telithromycin in Children With Otitis Media |
| Official title | Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 5 Days Azithromycin 10 mg/kg od Followed by 5 mg/kg od for 4 Days, in Children With Acute Otitis Media |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Otitis Media, Suppurative, Purulent |
| Intervention type | Drug |
| Interventions | Telithromycin, Azithromycin |
| Enrollment | 1,500 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Apr 17, 2006 |
| Last update posted | Apr 3, 2009 |
| Countries | Argentina, Brazil, Canada, Chile, Colombia, Costa Rica, Czechia, Dominican Republic, Guatemala, Israel, Panama, Peru and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: